These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17591784)

  • 1. Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog.
    Liu Q; Kriksunov IA; Moreau C; Graeff R; Potter BV; Lee HC; Hao Q
    J Biol Chem; 2007 Aug; 282(34):24825-32. PubMed ID: 17591784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5'-Diphosphate Ribose Template.
    Moreau C; Liu Q; Graeff R; Wagner GK; Thomas MP; Swarbrick JM; Shuto S; Lee HC; Hao Q; Potter BV
    PLoS One; 2013; 8(6):e66247. PubMed ID: 23840430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38.
    Liu Q; Kriksunov IA; Graeff R; Lee HC; Hao Q
    J Biol Chem; 2007 Feb; 282(8):5853-61. PubMed ID: 17182614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose".
    Watt JM; Graeff R; Thomas MP; Potter BVL
    Sci Rep; 2017 Nov; 7(1):16100. PubMed ID: 29170518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic adenosine 5'-diphosphate ribose analogs without a "southern" ribose inhibit ADP-ribosyl cyclase-hydrolase CD38.
    Swarbrick JM; Graeff R; Zhang H; Thomas MP; Hao Q; Potter BV
    J Med Chem; 2014 Oct; 57(20):8517-29. PubMed ID: 25226087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the mechanism of bovine CD38/NAD+glycohydrolase from the X-ray structures of its Michaelis complex and covalently-trapped intermediates.
    Egea PF; Muller-Steffner H; Kuhn I; Cakir-Kiefer C; Oppenheimer NJ; Stroud RM; Kellenberger E; Schuber F
    PLoS One; 2012; 7(4):e34918. PubMed ID: 22529956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of cyclizing NAD to cyclic ADP-ribose by ADP-ribosyl cyclase and CD38.
    Graeff R; Liu Q; Kriksunov IA; Kotaka M; Oppenheimer N; Hao Q; Lee HC
    J Biol Chem; 2009 Oct; 284(40):27629-36. PubMed ID: 19640843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase.
    Liu Q; Graeff R; Kriksunov IA; Jiang H; Zhang B; Oppenheimer N; Lin H; Potter BV; Lee HC; Hao Q
    J Biol Chem; 2009 Oct; 284(40):27637-45. PubMed ID: 19640846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic competence of the cADP-ribose-CD38 complex as an intermediate in the CD38/NAD+ glycohydrolase-catalysed reactions: implication for CD38 signalling.
    Cakir-Kiefer C; Muller-Steffner H; Oppenheimer N; Schuber F
    Biochem J; 2001 Sep; 358(Pt 2):399-406. PubMed ID: 11513738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acidic residues at the active sites of CD38 and ADP-ribosyl cyclase determine nicotinic acid adenine dinucleotide phosphate (NAADP) synthesis and hydrolysis activities.
    Graeff R; Liu Q; Kriksunov IA; Hao Q; Lee HC
    J Biol Chem; 2006 Sep; 281(39):28951-7. PubMed ID: 16861223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular effects and metabolic stability of N1-cyclic inosine diphosphoribose and its derivatives.
    Kirchberger T; Wagner G; Xu J; Cordiglieri C; Wang P; Gasser A; Fliegert R; Bruhn S; Flügel A; Lund FE; Zhang LH; Potter BV; Guse AH
    Br J Pharmacol; 2006 Oct; 149(4):337-44. PubMed ID: 16967053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Molecule CD38 Inhibitors: Synthesis of 8-Amino-
    Watt JM; Graeff R; Potter BVL
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmembrane glycoprotein CD38 is a catalytically active transporter responsible for generation and influx of the second messenger cyclic ADP-ribose across membranes.
    Franco L; Guida L; Bruzzone S; Zocchi E; Usai C; De Flora A
    FASEB J; 1998 Nov; 12(14):1507-20. PubMed ID: 9806760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase.
    Tohgo A; Munakata H; Takasawa S; Nata K; Akiyama T; Hayashi N; Okamoto H
    J Biol Chem; 1997 Feb; 272(7):3879-82. PubMed ID: 9020087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single residue at the active site of CD38 determines its NAD cyclizing and hydrolyzing activities.
    Graeff R; Munshi C; Aarhus R; Johns M; Lee HC
    J Biol Chem; 2001 Apr; 276(15):12169-73. PubMed ID: 11278881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the mechanistic understanding of human CD38-controlled multiple catalysis.
    Liu Q; Kriksunov IA; Graeff R; Munshi C; Lee HC; Hao Q
    J Biol Chem; 2006 Oct; 281(43):32861-9. PubMed ID: 16951430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic CD38 protein forms intact disulfides and is active in elevating intracellular cyclic ADP-ribose.
    Zhao YJ; Zhang HM; Lam CM; Hao Q; Lee HC
    J Biol Chem; 2011 Jun; 286(25):22170-7. PubMed ID: 21524995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium.
    Liu Q; Graeff R; Kriksunov IA; Lam CM; Lee HC; Hao Q
    Biochemistry; 2008 Dec; 47(52):13966-73. PubMed ID: 19117080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine CD38 exhibits prominent secondary NAD(+) cyclase activity.
    Ting KY; Leung CF; Graeff RM; Lee HC; Hao Q; Kotaka M
    Protein Sci; 2016 Mar; 25(3):650-61. PubMed ID: 26660500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallographic studies on human BST-1/CD157 with ADP-ribosyl cyclase and NAD glycohydrolase activities.
    Yamamoto-Katayama S; Ariyoshi M; Ishihara K; Hirano T; Jingami H; Morikawa K
    J Mol Biol; 2002 Feb; 316(3):711-23. PubMed ID: 11866528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.